Targeted radionuclide therapy enhances prostate cancer response to immunotherapies
Targeted radionuclide therapy has been found to create a favorable tumor microenvironment in prostate cancer that improves the effectiveness of immunotherapies. The research, presented at the Society of Nuclear Medicine and ...
Jul 13, 2020
0
6